mdlinx mdlinx
Physician Assistant Articles on MDLinx Top Read Articles
of 2012
Print

Positive predictive value of computed tomography coronary angiography in clinical practice
International Journal of Cardiology, 05/08/2012

Groothuis JGJ et al. – The positive predictive value (PPV) of computed tomography coronary angiography (CTCA) for detection of significant coronary artery disease (CAD) in patients with low to intermediate probability CAD that are clinically referred for non–invasive evaluation of chest pain is markedly lower than generally reported.

Methods
  • A total of 181 patients with low to intermediate pre–test probability CAD that were referred for non–invasive evaluation of chest pain underwent 64–slice CTCA.
  • CTCA was scored per segment as normal, non–obstructive CAD or obstructive CAD (>50% diameter stenosis).
  • All patients with obstructive CAD according to CTCA, underwent ICA. Significant CAD was defined as >50% diameter stenosis on ICA.

Results
  • According to CTCA, 65 (35.9%) patients had obstructive CAD.
  • In 26 (14.4%) patients, significant CAD was found by ICA.
  • The PPV for detection of significant CAD per patient, per vessel and per segment were 40.0% (26/65, 95% CI: 30.6–50.2%), 31.3% (36/115, 95% CI: 24.7–38.8%) and 25.5% (42/165; 95% CI: 20.3–31.4%), respectively.

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close